Adhesive Small Intestine Obstruction Clinical Trial
Official title:
Gastrografin Use in Small Bowel Obstruction Caused by Adherences
Adhesive small intestine obstruction (ASIO) is an important cause of hospital admission and
a very common disease. Any improvement in this field will benefit many patients by reducing
the operative rate. Patients with this disease are difficult to evaluate and to manage and
their treatment is controversial. Emergency surgery is mandatory when strangulation is
suspected or in the case of total obstruction. On the other hand, conservative non-operative
treatment is indicated in the case of partial obstruction. The role of water-soluble
contrast medium (Gastrografin®: GG) in ASIO is still debated with regard to the therapeutic
value.
The aim of our study was to determine the therapeutic role of Gastrografin in patients with
small intestine obstruction without strangulation caused by adherences (ASIO).
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment